Consistently, SGX-523, a small-molecule inhibitor of c-Met, restored the sensitivity and the downstream signaling of parental GBM cells after the overexpression of lnc-TALC (Fig. 4k, l and Supplementary Fig. 4g). Here, MET is linked to glioblastoma.